• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Judy E. Garber, M.D. M.P.H.

Associate Professor, Department of Medicine, Harvard Medical School

Director, Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute

Contact Info

Judy Garber
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: Smith 271
Phone: 617-632-2282
Fax: 617-632-2649
Judy_Garber@DFCI.harvard.edu

Assistant

Kathleen Brenton
Grants Management Specialist
Population Sciences
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: SM271
Phone: 617-632-5770
Fax: 617-632-2649
Kathleen_Brenton@dfci.harvard.edu

DF/HCC Program Affiliation

Reduction of Cancer Risk and Disparities
Breast Cancer
Cancer Epidemiology
Cancer Genetics

Research Abstract

Not Available.

Publications

  • Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak
    17349583
  • Schneider KA, Chittenden AB, Branda KJ, Keenan MA, Joffe S, Patenaude AF, Reynolds H, Dent K, Eubanks S, Goldman J, Leroy B, Warren NS, Taylor K, Vockley CW, Garber JE.Ethical issues in cancer genetics: I 1) whose information is it?.J Genet Couns 2006 Dec
    17106632
  • Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N.Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.J
    16818854
  • Carlson RW, Moench SJ, Hammond ME, Perez EA, Burstein HJ, Allred DC, Vogel CL, Goldstein LJ, Somlo G, Gradishar WJ, Hudis CA, Jahanzeb M, Stark A, Wolff AC, Press MF, Winer EP, Paik S, Ljung BM,.HER2 testing in breast cancer: NCCN Task Force report and re
    16813731
  • Burstein HJ, Mayer E, Patridge AH, O'Kane H, Litsas G, Come SE, Hudis CA, Goldstein DF, Muss HB, Winter EP, Garber JE.Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.Clin Breast Canc
    16800976
  • , Ganz PA, Kwan L, Somerfield MR, Alberts D, Garber JE, Offit K, Lippman SM.The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members.J Clin Oncol 2006 Jun 20;24(18):2948-57.
    16702579
  • Bevers TB, Anderson BO, Bonaccio E, Borgen PI, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Helvie M, Hoover S, Krontiras H, Shaw S, Singletary E, Sugg Skinner C, Smith ML, Tsangaris TN, Wiley EL, Williams C.Breast cancer scree
    16687096
  • Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, Foulkes WD, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchri
    16563180
  • Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade OI, Weber BL, Rebbeck TR.Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation c
    16510331
  • Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN,.Genetic/familial high-risk a
    16451772
  • Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE.Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.J Clin Oncol 2006 Feb 1;24(4):700-6.
    16446344
  • Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP.The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.Am J Surg Pathol 2006 Feb;30(2):230-6.
    16434898
  • Larson PS, Schlechter BL, de las Morenas A, Garber JE, Cupples LA, Rosenberg CL.Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction
    16314623
  • Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN.Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophos
    16243442
  • Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR.The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.Carcinogenesis 2006 Mar;27(3):599-605.
    16244359
  • Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS, Hodin R, Heitritter S, Moore F, Dluhy R, Sosa JA, Ocal IT, Benn DE, Marsh DJ, Robinson BG, Schneider K, Garber J, Arum SM, Korbonits M, Grossma
    16103922
  • Syngal S, Fox EA, Li C, Dovidio M, Eng C, Kolodner RD, Garber JE.Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing.JAMA 1999 Jul 21;282(3):247-53.
    10422993
  • Chabner E, Nixon A, Gelman R, Hetelekidis S, Recht A, Bornstein B, Connolly J, Schnitt S, Silver B, Manola J, Harris J, Garber J.Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage brea
    9626202
  • Schrag D, Kuntz KM, Garber JE, Weeks JC.Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.N Engl J Med 1997 May 15;336(20):1465-71.
    9148160